Mergers & Acquisitions

  • March 17, 2025

    RRJ Capital Leads $600M Investment In Aviation Biz Vista

    Private aviation group Vista, advised by Latham & Watkins LLP, on Monday revealed that it secured a $600 million equity investment from a group of investors led by Asian investment firm RRJ Capital.

  • March 17, 2025

    Chevron Buys 5% Of Hess With 'Confidence' In Merger Close

    Chevron Corp. disclosed Monday that it has purchased 4.99% of Hess Corp.'s outstanding common stock, a move that signals the oil giant's "continuing confidence" in completing its pending $53 billion acquisition of Hess despite ongoing arbitration challenges.

  • March 17, 2025

    Simpson Thacher Taps Kirkland Atty To Co-Lead Enviro Group

    Simpson Thacher & Bartlett LLP has hired a former Kirkland & Ellis LLP attorney, who is joining the firm in Washington, D.C., to co-lead its environmental practice and continue her work with the environmental issues involved in commercial transactions, the firm announced Monday.

  • March 17, 2025

    Activist Investor Calls For Reconstitution Of Parkland's Board

    Activist hedge fund Engine Capital on Monday called for a comprehensive reconstitution of Calgary, Alberta-based Parkland Corp.'s board of directors, saying that the current board has overseen "meaningful underperformance" and demonstrated "zero interest" in engaging with its shareholders.

  • March 17, 2025

    PepsiCo Buying Poppi Prebiotic Soda Brand In $1.65B Deal

    PepsiCo Inc. said Monday it has agreed to pay $1.65 billion for the "better-for-you" prebiotic soda brand Poppi, as the beverage giant looks to capitalize on growing consumer interest in health and wellness.

  • March 17, 2025

    4 Firms Guide Up To $1.14B Sale Of PE-Backed Biotech

    Taiho Pharmaceuticals on Monday announced plans to acquire private equity-backed Swiss biotechnology company Araris Biotech for up to $1.14 billion in a deal built by four law firms.

  • March 17, 2025

    Covington-Led AstraZeneca To Buy Belgian Biz For Up To $1B

    British-Swedish pharmaceutical giant AstraZeneca PLC said Monday that it has agreed to buy cancer immunotherapy business EsoBiotec in a deal worth up to $1 billion in cash to develop its capabilities in cell therapy.

  • March 14, 2025

    Antitrust Questions Earn Belt Line Deal A Deep Dive

    The Surface Transportation Board isn't going to let Norfolk Southern get away with calling its attempt to procure the remainder of a rail line a minor transaction, since it's been locked in antitrust litigation over the control of that line for years, according to an order Friday that deemed the transaction "significant."

  • March 14, 2025

    Market Turbulence Threatens To Stall IPO Recovery

    Stock market volatility is impeding a recovery in initial public offerings that market dealmakers hoped would begin by spring, prompting many IPO lawyers and advisers to defer hopes of a rebound until at least the second half of 2025.

  • March 14, 2025

    Legalese Aside, Live Nation Judge Keeps Damages Claims

    A New York federal judge refused Friday to pare back a lawsuit filed by the government and 40 states accusing Live Nation of quashing competition and hiking ticketing prices, preserving claims that artists have been forced to use Live Nation promotion services and deeming state attorneys general to have standing to seek damages.

  • March 14, 2025

    3 Firms Rep On $8.5B Crown Castle Fiber Assets Sale

    Paul Weiss-advised Crown Castle Inc. has agreed to sell its fiber segment for $8.5 billion in a push to transform the company into a pure-play U.S. tower business, in two deals guided on the buy-side by Kirkland and Simpson Thacher.

  • March 14, 2025

    FTC Probing $13B Marketing Mega-Deal

    Marketing communications giants Omnicom and Interpublic disclosed an in-depth Federal Trade Commission probe into their $13 billion merger, pumping the brakes on their ability to close the deal soon, but they said the expectation is nevertheless to finish by the second half of this year.

  • March 14, 2025

    Off The Bench: Ex-Jet Sues Over Favre Clip, New Soccer Build

    In this week's Off The Bench, a retired football superstar claims an argument with icon Brett Favre should have never been aired on television, one trading card company gets the upper hand on another in dueling antitrust suits, and an English soccer club opts for a new stadium over a rebuild of the old one.

  • March 14, 2025

    Taxation With Representation: Davis Polk, Paul Weiss

    In this week's Taxation With Representation, Mallinckrodt PLC and Endo Inc. combine, Rocket Cos. buys Redfin, and Endo divests its international pharmaceuticals business to Knight Therapeutics Inc.

  • March 14, 2025

    Skadden Tech Veteran Preps For AI's Planetary Revolution

    Kenton King helped open Skadden's Silicon Valley offices some 25 years ago and has lived and breathed tech for a majority of his career, so he's no stranger to so-called disruptors in the sector. But he said game-changers like artificial intelligence come along only once or twice in a lifetime.

  • March 14, 2025

    Toyota Group Unit Buys Radius Recycling In $1.34B Deal

    North American recycler Radius Recycling Inc., advised by Simpson Thacher & Bartlett LLP, has agreed to be bought by a U.S. subsidiary of White & Case LLP-led Toyota Tsusho Corp. in a $1.34 billion deal.

  • March 13, 2025

    SEC's Expansion Of Confidential Filings Likely To Spur Deals

    The U.S. Securities and Exchange Commission's latest effort to expand companies' ability to confidentially file for more securities offerings during initial stages should accelerate the pace of public issuances, according to capital markets lawyers.

  • March 13, 2025

    StubHub, Figma Pursue IPOs, And More Deal Rumors

    StubHub and Figma are pursuing IPOs, Granicus' owners are exploring a $4 billion sale, and deals tied to Reese Witherspoon and Eminem could be in the pipeline. Here, Law360 breaks down these and other notable deal rumors from the past week.

  • March 13, 2025

    6 Firms Steer $6.7B Mallinckrodt, Endo Pharma Merger

    Six law firms are guiding a $6.7 billion merger between Ireland's Mallinckrodt PLC and Pennsylvania-based Endo Inc. on a deal announced Thursday that the companies said will create a global pharmaceutical industry leader with projected 2025 revenues of $3.6 billion.

  • March 13, 2025

    Founder Wants $14.7M In Logistics Developer SPAC Dispute

    The founder of a Latin America-based logistics property developer told a Florida federal court that he is owed at least $14.7 million as part of a 2024 special purpose acquisition company merger.

  • March 13, 2025

    Amid Del. Corporate Law Overhaul Push, Texas Turns Up Heat

    As Delaware lawmakers advance changes to the state's general corporation law — aimed in part at stopping companies from moving their corporate charters — they are facing increased pressure from their counterparts in Texas, where legislation appears to be on a fast dash in an attempt to convince more businesses to make it their legal home.

  • March 13, 2025

    Del.'s Divisive Corporate Law Rework Passes In State Senate

    Divisive amendments to Delaware's general corporation law cleared the state Senate Thursday with multiple questions but little debate and without dissenting votes, and will now be sent to the House amid warnings that failure to approve could weaken the state's standing as a top corporate charter hub.

  • March 13, 2025

    Judge Orders Reinstatement Of Many Fired Federal Workers

    A California federal judge on Thursday ordered the immediate reinstatement of certain probationary employees fired from six federal agencies, saying the Office of Personnel Management did not have the authority to direct those terminations, making the firings "unlawful."

  • March 13, 2025

    UK Clears Keysight's £1.2B Offer For Telecoms Biz Spirent

    Britain's antitrust authority said Thursday it has allowed U.S. technology company Keysight Technologies Inc. to proceed with its planned £1.16 billion ($1.5 billion) acquisition of Spirent Communications PLC, a U.K. telecoms testing specialist.

  • March 12, 2025

    Capital One Nearly Bought Frank For $125M, Javice Jury Told

    A Capital One investment banker told a New York federal jury on Wednesday that the lender was eyeing student financial aid startup Frank for a potential $125 million acquisition before backing out, $50 million less than what JPMorgan Chase & Co. ultimately paid for the company, the result of what prosecutors say was a scheme to fraudulently induce JPMorgan to make the purchase.

Expert Analysis

  • Series

    Round-Canopy Parachuting Makes Me A Better Lawyer

    Author Photo

    Similar to the practice of law, jumping from an in-flight airplane with nothing but training and a few yards of parachute silk is a demanding and stressful endeavor, and the experience has bolstered my legal practice by enhancing my focus, teamwork skills and sense of perspective, says Thomas Salerno at Stinson.

  • Dealmaker Lessons From CFIUS' New Enforcement Webpage

    Author Photo

    The Committee on Foreign Investment in the United States’ recently launched webpage, which details the actions — and inactions — that led to enforcement activity, provides important insights for dealmakers about filing requirements, mitigation commitments and the cost of noncompliance, say attorneys at Dechert.

  • Presidents And Precedents May Direct Khan's Future Course

    Author Photo

    While the Sept. 25 technical expiration of Federal Trade Commission Chair Lina Khan's term demands no immediate action, it does invite an analysis of commission policy and post-election possibilities, says Axinn's Richard Dagen, a former FTC official.

  • What To Expect From Calif. Bill Regulating PE In Healthcare

    Author Photo

    A California bill currently awaiting Gov. Gavin Newsom's approval, intended to increase oversight over private equity and hedge fund investments in healthcare, is emblematic of recent increased scrutiny of investments in the space, and may affect transactions and operations in California in a number of ways, say attorneys at Ropes & Gray.

  • Why Now Is The Time For Law Firms To Hire Lateral Partners

    Author Photo

    Partner and associate mobility data from the second quarter of this year suggest that there's never been a better time in recent years for law firms to hire lateral candidates, particularly experienced partners — though this necessitates an understanding of potential red flags, say Julie Henson and Greg Hamman at Decipher Investigative Intelligence.

  • Google And The Next Frontier Of Divestiture Antitrust Remedy

    Author Photo

    The possibility of a large-scale divestiture in the Google search case comes on the heels of recent requests of business breakups as remedies for anticompetitive conduct, and companies should prepare for the likelihood that courts may impose divestiture remedies in the event of a liability finding, say Lauren Weinstein and Nathaniel Rubin at MoloLamken.

  • Considering Possible PR Risks Of Certain Legal Tactics

    Author Photo

    Disney and American Airlines recently abandoned certain litigation tactics in two lawsuits after fierce public backlash, illustrating why corporate counsel should consider the reputational implications of any legal strategy and partner with their communications teams to preempt public relations concerns, says Chris Gidez at G7 Reputation Advisory.

  • 3 M&A Elements To Master In A Volatile Economy

    Author Photo

    The current M&A market requires a strategic approach to earnouts, past-due accounts payable and employee retention in order to mitigate risk and drive successful outcomes, says Robert Harig at Robbins DiMonte.

  • It's No Longer Enough For Firms To Be Trusted Advisers

    Author Photo

    Amid fierce competition for business, the transactional “trusted adviser” paradigm from which most firms operate is no longer sufficient — they should instead aim to become trusted partners with their most valuable clients, says Stuart Maister at Strategic Narrative.

  • Del. Dispatch: Drafting Lessons For Earnout Provisions

    Author Photo

    The Delaware Court of Chancery's recent decision in Medal v. Beckett Collectibles provides guidance for avoiding ambiguity in provisions relating to the acceleration of earnout payments under specified circumstances, and provisions mandating good faith negotiations before bringing earnout litigation, say attorneys at Fried Frank.

  • Tax Traps In Acquisitions Of Financially Distressed Targets

    Excerpt from Practical Guidance
    Author Photo

    Parties to the acquisition of an insolvent or bankrupt company face myriad tax considerations, including limitations on using the distressed company's tax benefits, cancellation of indebtedness income, tax lien issues and potential tax reorganizations.

  • New Lessons On Managing Earnout Provision Risks

    Author Photo

    Earnout provisions can be a useful tool for bridging valuation gaps in M&A, particularly in developmental-stage pharmaceutical transactions, but the Delaware Chancery Court’s recent decision in Shareholder Representative Services v. Alexion sheds new light on the inherent risks and best practices for managing them, say attorneys at Cleary.

  • SBA Proposal Materially Alters Contractor Recertification

    Author Photo

    The Small Business Administration's new proposed rule on recertification affects eligibility for set-aside contracts, significantly alters the landscape for mergers and acquisitions in the government contracts industry, and could have other unintended downstream consequences, says Sam Finnerty at PilieroMazza.

  • Navigating A Potpourri Of Possible Transparency Act Pitfalls

    Author Photo

    Despite the Financial Crimes Enforcement Network's continued release of guidance for complying with the Corporate Transparency Act, its interpretation remains in flux, making it important for companies to understand potentially problematic areas of ambiguity in the practical application of the law, say attorneys at Sidley.

  • EU Merger Control Concerns Remain After ECJ Illumina Ruling

    Author Photo

    The recent European Court of Justice judgment in Illumina-Grail is a welcome check on the commission's power to review low-threshold transactions, but with uncertainty persisting under existing laws and discretion left to national regulators, many pitfalls in European Union merger control remain, says Matthew Hall at McGuireWoods.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!